Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
129.8 USD | +4.28% | +5.12% | +34.58% |
30/05 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
30/05 | Sector Update: Health Care | MT |
Sales 2024 * | 1.94B 162B | Sales 2025 * | 2.82B 235B | Capitalization | 12.27B 1,024B |
---|---|---|---|---|---|
Net income 2024 * | 327M 27.28B | Net income 2025 * | 988M 82.41B | EV / Sales 2024 * | 5.79 x |
Net cash position 2024 * | 1.03B 86.1B | Net cash position 2025 * | 2.54B 212B | EV / Sales 2025 * | 3.45 x |
P/E ratio 2024 * |
38.7
x | P/E ratio 2025 * |
12.2
x | Employees | 1,314 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.03% |
Latest transcript on Sarepta Therapeutics, Inc.
1 day | +4.28% | ||
1 week | +5.12% | ||
Current month | -0.06% | ||
1 month | -0.86% | ||
3 months | +0.86% | ||
6 months | +53.69% | ||
Current year | +34.58% |
Managers | Title | Age | Since |
---|---|---|---|
Douglas Ingram
CEO | Chief Executive Officer | 61 | 26/17/26 |
Ian Estepan
DFI | Director of Finance/CFO | 48 | 01/15/01 |
Bilal Arif
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Ingram
CEO | Chief Executive Officer | 61 | 26/17/26 |
M. Wilsey
CHM | Chairman | 71 | 31/09/31 |
Richard Barry
BRD | Director/Board Member | 65 | 02/15/02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.63% | 1 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 129.9 | +4.35% | 16,976,044 |
30/24/30 | 124.4 | +7.05% | 4,369,473 |
29/24/29 | 116.2 | +2.58% | 1,942,588 |
28/24/28 | 113.3 | -8.21% | 2,977,049 |
24/24/24 | 123.5 | -2.89% | 1,033,844 |
Delayed Quote Nasdaq, May 01, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.58% | 12.27B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+77.64% | 8.87B | |
+7.26% | 7.75B |
- Stock Market
- Equities
- SRPT Stock